trametinib

neuroblastoma ras oncogene ; Mus musculus







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34002029 Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia. 2021 Dec 2
2 32576961 Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia. 2020 Nov 2
3 26967478 MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma. 2016 Feb 1